A new analysis from the JUPITER study shows that CRESTOR(R) (rosuvastatin calcium) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p =0.007) compared to placebo ...
Sourse: More Info
Monday, March 30, 2009
Video: CRESTOR(R) Reduced Risk of Blood Clots in the Veins
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment